glymotif
A glycan motif matcher trading convenience wrappers for speed, strictness and explicit specs.
Comparison · Analytics
ibdsim2 vs malariasimulation
A side-by-side editorial comparison of ibdsim2 and malariasimulation — release velocity, themes, recent moves, and the top alternatives to consider.
Shared themes:simulationr-packages
ibdsim2 vs malariasimulation: at a glance
What is ibdsim2?
A pedigree IBD simulator that absorbed its own web app and now optimises for dense marker panels.
ibdsim2 simulates identity-by-descent sharing along chromosomes for arbitrary pedigrees, in both autosomal and X-chromosomal form, with downstream tools for segment statistics, pattern finding and distribution plots. Since 2.1.0 the Shiny front end lives inside the package and launches via launchApp() rather than sitting in a separate repository. The latest release is performance work, with profileSimIBD() substantially sped up for dense marker panels and ibdsim() skipping recombination in pedigree branches that cannot affect the result.
What is malariasimulation?
An individual-based malaria model that grew a second parasite species, then froze itself for reproducibility.
malariasimulation is an individual-based transmission model whose 2.0 line added a full Plasmodium vivax implementation alongside the existing P. falciparum one, including hypnozoites, competing hazards, vivax-specific drug handling, an equilibrium solution and dedicated outputs. The most recent entry is not a code release at all but a coordinated malariaverse_01_2025 tag applied across the package suite, freezing every package at a matching version so existing analyses can be reproduced after the suite moves on. The record here is thin, two entries spanning sixteen months, so the visible cadence understates the work in the underlying repository.
ibdsim2 vs malariasimulation: editorial side-by-side
ibdsim2
2.5ANALYTICS
A pedigree IBD simulator that absorbed its own web app and now optimises for dense marker panels.
◆ Current state
ibdsim2 simulates identity-by-descent sharing along chromosomes for arbitrary pedigrees, in both autosomal and X-chromosomal form, with downstream tools for segment statistics, pattern finding and distribution plots. Since 2.1.0 the Shiny front end lives inside the package and launches via launchApp() rather than sitting in a separate repository. The latest release is performance work, with profileSimIBD() substantially sped up for dense marker panels and ibdsim() skipping recombination in pedigree branches that cannot affect the result.
◆ Where it's heading
Two long-running threads. One is the app as a first-class part of the package, which has been getting input validation, dependency checks and plotting fixes release after release, treating a research GUI as software to be maintained rather than a demo. The other is numerical care: the built-in recombination map was rebuilt in 2.3.0 with better chromosome endpoints and a thinning algorithm that cut it from about 38,000 points to 14,000 without losing accuracy, and IBD segment merging has been made consistent across the realised-coefficient functions. The maintainer flags repeatedly that seeded results may differ across versions, which is the right disclosure for a simulator used in published analyses.
◆ Prediction
The recent work points at further speed on dense panels and continued hardening of app input handling, both of which have appeared in each of the last several releases. Nothing here signals a new modelling capability on the way.
malariasimulation
0.0ANALYTICS
An individual-based malaria model that grew a second parasite species, then froze itself for reproducibility.
◆ Current state
malariasimulation is an individual-based transmission model whose 2.0 line added a full Plasmodium vivax implementation alongside the existing P. falciparum one, including hypnozoites, competing hazards, vivax-specific drug handling, an equilibrium solution and dedicated outputs. The most recent entry is not a code release at all but a coordinated malariaverse_01_2025 tag applied across the package suite, freezing every package at a matching version so existing analyses can be reproduced after the suite moves on. The record here is thin, two entries spanning sixteen months, so the visible cadence understates the work in the underlying repository.
◆ Where it's heading
The direction visible in these entries is toward being a suite rather than a package. The snapshot tag is explicit that packages are installed together at one tag rather than mixed with main, which is the versioning discipline of a research platform whose users publish against specific model versions. On the modelling side, the vivax work was not a parameter addition but a distinct biology, with immunity structures removed rather than reused, indicating the model now carries two species with genuinely different natural histories.
◆ Prediction
The snapshot describes itself as freezing state immediately before an upcoming update, so the next visible release should be that update across the suite rather than any single package. Whether it extends the vivax model or the falciparum one is not indicated here.
Alternatives to ibdsim2 and malariasimulation
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ibdsim2 or malariasimulation.
glyrepr
The type system the rest of the glycan stack is built on, being hardened one breaking change at a time.
glyanno
Glycan annotation stops depending on the database having seen the structure before.
glydraw
SNFG glycan cartoons stopped being pictures and became ggplot2 geoms, guides and axis labels.
glyenzy
Glycan biosynthesis as a traceable enzyme graph, now including sulfation and gaps it can bridge.
KLINK
Forensic kinship testing with linked STR markers, now peer-reviewed and taking data from anywhere.
See all ibdsim2 alternatives → · See all malariasimulation alternatives →
Recent activity from ibdsim2 and malariasimulation
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 11d agoibdsim2profileSimIBD() sped up for dense marker panels; segment merging fixed
- 2mo agomalariasimulationCoordinated suite snapshot tag for reproducible installs
- 8mo agoibdsim2Segment-distribution merge argument, and function-valued parameters
- 1y agoibdsim2Built-in decode19 recombination map rebuilt, cutting 38k points to 14k
- 1y agoibdsim2Consistent IBD segment merging across the realised-coefficient functions
- 1y agomalariasimulationPlasmodium vivax model lands: hypnozoites, competing hazards, equilibrium ⚡
- 1y agoibdsim2Built-in pedigree labels revised; extra inbred examples added
- 1y agoibdsim2The Shiny front end moves into the package and gains X-chromosomal simulation ⚡
Frequently asked questions
What is the difference between ibdsim2 and malariasimulation?
Both compete on the same themes — simulation, r-packages — within Analytics. ibdsim2 is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is ibdsim2 better than malariasimulation?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. ibdsim2 is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to ibdsim2?
Top ibdsim2 alternatives in Analytics are ranked by recent ship velocity. Browse the "ibdsim2 alternatives" section above for the current picks, or visit /alternatives/ibdsim2 for the full list with editorial commentary on each.
What are the best alternatives to malariasimulation?
Top malariasimulation alternatives in Analytics are ranked by recent ship velocity. Browse the "malariasimulation alternatives" section above for the current picks, or visit /alternatives/malariasimulation for the full list with editorial commentary on each.